id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0402-0023,FDA,FDA-2013-N-0402,"Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives;
Public Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2016-03-09T05:00:00Z,2016,3,2016-03-09T05:00:00Z,,2024-11-12T05:59:06Z,2016-05221,1,0,0900006481eb47b7